Poor muscle health and cardiometabolic risks associated with antidepressant treatment
- PMID: 39315407
- DOI: 10.1002/oby.24085
Poor muscle health and cardiometabolic risks associated with antidepressant treatment
Abstract
Objective: This study aims to investigate whether antidepressant users display differences in fat distribution and muscle composition relative to non-users and to explore risk factors for developing cardiovascular disease (CVD) and type 2 diabetes.
Methods: The study used quantitative adipose and muscle tissue measures derived from magnetic resonance imaging data from UK Biobank (N = 40,174). Fat distribution and muscle composition of selective serotonin reuptake inhibitor (SSRI) and tricyclic antidepressant (TCA) users were compared with sex-, age-, and BMI-matched control individuals. Cox regression models were used to test for increased risk of developing CVD and type 2 diabetes.
Results: SSRI users had more visceral fat, smaller muscle volume, and higher muscle fat infiltration compared with matched control individuals. Female users showed a larger increase in BMI over time compared with male users. However, male users displayed an unhealthier body composition profile. Male SSRI users also had an increased risk of developing CVD. Both male and female TCA users showed lower muscle volume and an increased risk of developing type 2 diabetes.
Conclusions: Adverse changes in body composition of antidepressant users are not captured by tracking the body weight or the BMI of the patients. These changes may lead to a worsened cardiometabolic risk profile.
© 2024 The Obesity Society.
References
REFERENCES
-
- McCool A, Lukas K, Hayes P, Kelly D. Antidepressant medication prescribing patterns in Irish general practice from 2016 to 2020 to assess for long‐term use. Ir J Med Sci. 2022;191:2239‐2246.
-
- Morkem R, Barber D, Williamson T, Patten SB. A Canadian primary care sentinel surveillance network study evaluating antidepressant prescribing in Canada from 2006 to 2012. Can J Psychiatry. 2015;60:564‐570.
-
- Olfson M, Marcus SC. National patterns in antidepressant medication treatment. Arch Gen Psychiatry. 2009;66:848‐856.
-
- Huijbregts KM, AdriaanW H, Slottje P, van Balkom AJLM, Batelaan NM. Long‐term and short‐term antidepressant use in general practice: data from a large cohort in The Netherlands. Psychother Psychosom. 2017;86:362‐369.
-
- Lunghi C, Dugas M, Leclerc J, et al. Global prevalence of antidepressant drug utilization in the community: protocol for a systematic review. BMJ Open. 2022;12:e062197.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
